Prelude Therapeutics Inc - PRLD
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | — | A | A | 38,000.0 | 0.0 | 0.0 | 38,000.0 | View | |
| Jun 10, 2026 | — | A | A | 38,000.0 | 0.0 | 0.0 | 38,000.0 | View | |
| Jun 10, 2026 | — | A | A | 38,000.0 | 0.0 | 0.0 | 38,000.0 | View | |
| Jun 10, 2026 | — | A | A | 38,000.0 | 0.0 | 0.0 | 38,000.0 | View | |
| Jun 10, 2026 | — | A | A | 38,000.0 | 0.0 | 0.0 | 38,000.0 | View | |
| Jun 10, 2026 | — | A | A | 38,000.0 | 0.0 | 0.0 | 38,000.0 | View | |
| Jun 10, 2026 | — | A | A | 38,000.0 | 0.0 | 0.0 | 38,000.0 | View | |
| May 04, 2026 | Chief Medical Officer | A | A | 450,000.0 | 4.7 | 2,115,000.0 | 450,000.0 | View | |
| Apr 28, 2026 | — | J | A | 1,407,000.0 | — | — | 1,407,000.0 | View | |
| Apr 28, 2026 | — | J | D | 1,407,000.0 | — | — | 6,475,882.0 | View | |
| Apr 23, 2026 | — | P | A | 1,126,126.0 | 4.44 | 4,999,999.44 | 1,126,126.0 | View | |
| Apr 23, 2026 | — | P | A | 1,689,189.0 | 4.44 | 7,499,999.16 | 11,808,945.0 | View | |
| Apr 23, 2026 | — | P | A | 1,126,126.0 | 4.44 | 4,999,999.44 | 1,126,126.0 | View | |
| Apr 23, 2026 | — | P | A | 1,689,189.0 | 4.44 | 7,499,999.16 | 11,808,945.0 | View | |
| Apr 22, 2026 | — | P | A | 2,137,651.0 | 4.4399 | 9,490,956.67 | 20,105,994.0 | View | |
| Apr 22, 2026 | — | P | A | 114,601.0 | 4.4399 | 508,816.98 | 1,678,273.0 | View |